Blood Additive

Pioneering a unique artificial blood supplement

SanguiBioTech is focusing on disease treatment arising from an acute or chronic decrease in oxygen supply. To this end it has developed a new type of oxygen carrier based on naturally occurring haemoglobin.

SanguiBioTech 's oxygen carrier has a range of promising appliances with an extremely large market potential. Not only can it provide an alternative to the current use of donor blood in treating blood loss, it can also - as a world-wide first - be used as a blood supplement to treat compromised blood supply, which gives it a wide indication field. To insure a rapid market entry the carrier will be initially approved for use in shock lung, also known as acute respiratory deficiency syndrome (ARDS).

For more information please refer to this brief project summary (PDF-File / 127kB).